Episode 321: A couple of new studies that will confirm or change your practice

In episode 321, James and Mike discuss two interesting studies. One is on the duration of antibiotics for community-acquired pneumonia and the other about the impact of total knee replacement on the overall quality of life. Interestingly, the results of these studies were different although that may have been the fact that one was on pneumonia and the other on TKR.

Show notes Read more »

Episode 320: PREMIUM – Our spin on the latest type 2 diabetes publications

In episode 320, Mike and James PREMIUM out yet again and talk about 3 new diabetes publications that our listeners have asked us about.

Show notes

1) LEADER Study

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

N Engl J Med 2016; 375:311-22 Read more »

Episode 319: Listener questions and some questionable answers – PART IV

In episode 319, Mike and James begin questioning the number of questions they are having to answer but plough forward and talk about confidence intervals, anticoagulation bridging, hormone replacement and finally bring it all home with comments on DRE. 

Show notes Read more »

Episode 318: Listener questions and some questionable answers – PART III

In episode 318, Mike and James attempt to answer even more questions. We run the spectrum from steroid injections, to repeat bone density measurements, to vortioxetine, generic drugs, and sitagliptin. Bottom line - please stop going to industry sponsored CME.

Show notes

1) Generic drugs Read more »

Episode 317: Listener questions and some questionable answers – PART II

In episode 317, James and Mike continue with their question and answering quest. We offer our spin on cardiovascular risk assessment, prostate screening, creatinine clearance and at the end leave our listeners questioning our podcast.

Show notes

1) Bridge Over Diagnosis - a parody of Bridge Over Troubled Water Read more »

Episode 316: Listener questions and some questionable answers

In episode 316, James and Mike finally get to the back-log of listener questions. We talk about stats, risk factors, guidelines and of course what podcast wouldn’t be complete without mentioning statins. 

Show notes

1) Critical appraisal by and for dummies – three podcast episodes Read more »

Episode 315: A way to think about antidotes for anticoagulants - PART II

In episode 315, James, Mike and Peter Loewen finish talking about the whole issue of antidotes for anticoagulants. In this podcast we focus on how we can have the conversation about these products with patients to allow for as much as possible, shared decision-making.

Show notes

Slides from Peter Loewen’s talk Read more »

Episode 314: A way to think about antidotes for anticoagulants

In episode 314, James and Mike welcome Peter Loewen back to the podcast to help us think through how we should frame the whole issue around antidotes for anticoagulants. At the end, we realise it is much more than just do we or do we not have an antidote.

Show notes

Slides from Peter Loewen’s talk Read more »